Beam Therapeutics Inc
Biotechnology
Healthcare
BEAM
82.41 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
14.17
52 week high
34.09
high
17.04
52 week low
14.54
low
13.54
growth
-31.28 %
previous Close
14.54
P/E ratio
-14
market cap
2.38 B
div yield
0
net incoming
-96.67 M
-6.17 %
net profit margin
-677.47 %
95.00 %
operating incoming
-106.50 M
-1.53 %
net change in cash
-56.01 M
-1.00 %
cash on hand
230 M
-21.37 %
cost of revenue
5.48 M
-1.81 %
top